Morning Market Movers By: Benzinga via Benzinga October 06, 2014 at 09:42 AM EDT Durata Therapeutics (NASDAQ: DRTX) shares gained 72.91% to $24.00 after Actavis (NYSE: ACT) announced its plans to buy Durata ... Read More >> Related Stocks: Actavis Plc Arotech Corp Becton Dickinson Chimerix Inc Conn's Inc Digital Ally Inc Gopro Inc Cl A Hewlett-Packard Petrobras - Petroleo Brasileiro S.A. Voxx Intl Corp